Hero image with Pittsburgh background pittplusme.org/study/1356

STUDY BASICS

Are you the parent of a child ages 12-17 who has been diagnosed with moderate to severe eczema? If so, your child may be eligible to participate in a study to help researchers evaluate an investigational drug called upadacitinib, which is being tested as a treatment for several inflammatory diseases, including eczema. Compensation provided.


IRB:
  33342/25A - A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitnib in Combination with Topical Corticosteroids in Adolescent and Adult Subjects with Moderate to Severe Atopic Dermatitis


Age Range
AGE:   12 - 17

Duration VISITS:  multiple

Location LOCATION: 
Falk Medical Building - Oakland
Compensation COMPENSATION: 
Yes
Phone Number PHONE NUMBER:
1-866-438-8230
I'M INTERESTED
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   ShareShare   TweetTweet   Linked-InLinked-In
Search Icon pittplusme.org/study/1356
OR
Phone Number PHONE NUMBER:
1-866-438-8230

MEET THE RESEARCHER


Laura Ferris

Laura Korb Ferris, MD, PhD, is Associate Professor of Dermatology at the University of Pittsburgh School of Medicine, and is also the Director of Clinical Trials for the Department of Dermatology. Dr. Ferris earned her doctorate in immunology from Johns Hopkins University and her medical degree from the University of Maryland.




PittPlusMe.org 1-866-438-8230 PittPlusMe@pitt.edu
@PittPlusMe share tweet